Independence Holding (IHC) 10-Q 8 Aug 19 2019 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2019	Aug. 05, 2019
Details
Registrant Name	INDEPENDENCE HOLDING COMPANY
Registrant CIK	0000701869
SEC Form	10-Q
Period End date	Jun. 30, 2019
Fiscal Year End	--12-31
Trading Symbol	IHC
Tax Identification Number (TIN)	58-1407235
Number of common stock shares outstanding		14,892,668
Filer Category	Accelerated Filer
Current with reporting	Yes
Small Business	true
Emerging Growth Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-32244
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	96 CUMMINGS POINT ROAD
Entity Address, City or Town	STAMFORD
Entity Address, State or Province	CT
Entity Address, Postal Zip Code	06902
City Area Code	203
Local Phone Number	358-8000
Title of 12(b) Security	Common Stock, $1.00 par value
Security Exchange Name	NYSE
Entity Interactive Data Current	Yes
Entity Shell Company	false
Amendment Flag	false
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q2

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Investments
Short-term Investments	$ 50	$ 1,050
Securities Purchased under Agreements to Resell	38,864	12,063
Debt Securities, Available-for-sale	461,426	453,464
Equity Securities, FV-NI	5,543	5,166
Other Investments	13,328	13,192
Investments	519,211	484,935
Cash and Cash Equivalents, at Carrying Value	14,982	26,173
Premiums Receivable, Net	25,014	24,412
Reinsurance Recoverables, Including Reinsurance Premium Paid	367,241	368,731
Goodwill	60,205	50,697
Other Assets	84,272	82,568
Assets, Total	1,070,925	1,037,516
Liabilities
Liability for Claims and Claims Adjustment Expense	168,984	160,115
Liability for Future Policy Benefit, before Reinsurance	205,355	208,910
Deposit Contracts, Liabilities	141,523	141,635
Unearned Premiums	14,636	5,557
Policyholder Account Balance	11,757	10,939
Reinsurance Payable	3,837	3,613
Other Liabilities	54,420	53,133
Liabilities	600,512	583,902
Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount	2,271	2,183
TOTAL LIABILITIES AND EQUITY	1,070,925	1,037,516
STOCKHOLDERS' EQUITY:
Preferred Stock, Value, Issued	0	0
Common Stock, Value, Issued	18,625	18,625
Additional Paid in Capital, Common Stock	121,586	124,395
Accumulated Other Comprehensive Income (Loss), Net of Tax	2,298	(8,310)
Treasury stock, at cost; 3,715,693 and 3,747,210 shares	67,428	66,392
Retained Earnings (Accumulated Deficit)	393,018	380,431
TOTAL IHC STOCKHOLDERS' EQUITY	468,099	448,749
Stockholders' Equity Attributable to Noncontrolling Interest	43	2,682
TOTAL EQUITY	$ 468,142	$ 451,431

Consolidated Balance Sheets - P

Consolidated Balance Sheets - Parenthetical - $ / shares	Jun. 30, 2019	Dec. 31, 2018
Details
Preferred Stock, Par or Stated Value Per Share	$ 1	$ 1
Preferred Stock, Shares Authorized	100,000	100,000
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 1	$ 1
Common Stock, Shares Authorized	23,000,000	23,000,000
Common Stock, Shares, Issued	18,625,458	18,625,458
Common Stock, Shares, Outstanding	14,909,765	14,878,248
Treasury Stock, Shares	3,715,693	3,747,210

Consolidated Income Statement

Consolidated Income Statement - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Revenues
Premiums Earned, Net	$ 84,947	$ 77,334	$ 167,736	$ 156,826
Net Investment Income	4,134	3,687	8,130	7,368
Insurance Commissions and Fees	3,707	4,585	7,895	9,796
Other Income	879	(295)	4,563	(446)
Gain (Loss) on Investments	1,455	(423)	1,626	(352)
Revenues	95,122	84,888	189,304	173,192
Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale
Other than Temporary Impairment Losses, Investments, Available-for-sale Securities	0	0	646	0
Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Portion in Other Comprehensive Loss, before Tax, Including Portion Attributable to Noncontrolling Interest	0	0	0	0
Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net, Available-for-sale Securities	0	0	646	0
Operating Expenses
Policyholder Benefits and Claims Incurred, Net	44,410	33,701	87,529	69,608
Selling, General and Administrative Expense	42,206	41,693	82,735	85,036
Benefits, Losses and Expenses	86,616	75,394	170,264	154,644
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	8,506	9,494	19,040	18,548
Income Tax Expense (Benefit)	1,590	2,652	3,234	4,658
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	6,916	6,842	15,806	13,890
Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest	27	24	144	40
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest	42	61	88	132
Net Income (Loss) Attributable to Parent	$ 6,847	$ 6,757	$ 15,574	$ 13,718
Earnings Per Share, Basic	$ 0.46	$ 0.46	$ 1.04	$ 0.93
Weighted Average Number of Shares Outstanding, Basic	14,929	14,799	14,939	14,815
Earnings Per Share, Diluted	$ 0.46	$ 0.45	$ 1.04	$ 0.91
Weighted Average Number of Shares Outstanding, Diluted	14,948	15,128	15,007	15,101

Condensed Consolidated Statemen

Condensed Consolidated Statement of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Details
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 6,916	$ 6,842	$ 15,806	$ 13,890
Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax
Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Tax	6,250	(2,855)	13,444	(7,983)
Other Comprehensive Income (Loss), Securities, Available-for-sale, Tax	1,311	(603)	2,836	(1,694)
Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax	4,939	(2,252)	10,608	(6,289)
Other Comprehensive Income (Loss), Net of Tax	4,939	(2,252)	10,608	(6,289)
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest	11,855	4,590	26,414	7,601
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest
Net Income (Loss) Attributable to Noncontrolling Interest	69	85	232	172
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest	0	0	0	0
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest	69	85	232	172
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$ 11,786	$ 4,505	$ 26,182	$ 7,429

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	AOCI Attributable to Parent	Treasury Stock	Retained Earnings	Parent	Noncontrolling Interest
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2017	$ 434,243	$ 18,625	$ 124,538	$ (4,598)	$ (63,404)	$ 356,383	$ 431,544	$ 2,699
Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest	13,758					13,718	13,718	40
Other Comprehensive Income (Loss), Net of Tax	(6,289)			(6,289)			(6,289)	0
Treasury Stock, Value, Acquired, Cost Method	(3,147)				(3,147)		(3,147)	0
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders	(25)						0	(25)
Common stock dividend	(2,222)					(2,222)	(2,222)	0
Sharebased Compensation Effect On Stockholders Equity	591		480		111		591	0
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2018	436,496	18,625	125,018	(11,237)	(66,440)	367,913	433,879	2,617
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2018	434,414	18,625	124,774	(8,985)	(65,996)	363,378	431,796	2,618
Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest	6,781					6,757	6,757	24
Other Comprehensive Income (Loss), Net of Tax	(2,252)			(2,252)			(2,252)	0
Treasury Stock, Value, Acquired, Cost Method	(505)				(505)		(505)	0
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders	(25)						0	(25)
Common stock dividend	(2,222)					(2,222)	(2,222)	0
Sharebased Compensation Effect On Stockholders Equity	305		244		61		305	0
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2018	436,496	18,625	125,018	(11,237)	(66,440)	367,913	433,879	2,617
Cumulative Effect of New Accounting Principle in Period of Adoption	(413)			(350)		34	(316)	(97)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2018	451,431	18,625	124,395	(8,310)	(66,392)	380,431	448,749	2,682
Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest	15,718					15,574	15,574	144
Other Comprehensive Income (Loss), Net of Tax	10,608			10,608			10,608	0
Treasury Stock, Value, Acquired, Cost Method	(1,599)				(1,599)		(1,599)	0
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests	(3,392)		(1,012)				(1,012)	(2,380)
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders	(403)						0	(403)
Common stock dividend	(2,987)					(2,987)	(2,987)	0
Sharebased Compensation Effect On Stockholders Equity	(1,234)		(1,797)		563		(1,234)	0
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2019	468,142	18,625	121,586	2,298	(67,428)	393,018	468,099	43
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2019	461,076	18,625	122,055	(2,641)	(65,926)	386,164	458,277	2,799
Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest	6,874					6,847	6,847	27
Other Comprehensive Income (Loss), Net of Tax	4,939			4,939			4,939	0
Treasury Stock, Value, Acquired, Cost Method	(1,508)				(1,508)		(1,508)	0
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests	(3,392)		(1,012)				(1,012)	(2,380)
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders	(403)						0	(403)
Common stock dividend	7					7	7	0
Sharebased Compensation Effect On Stockholders Equity	549		543		6		549	0
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2019	$ 468,142	$ 18,625	$ 121,586	$ 2,298	$ (67,428)	$ 393,018	$ 468,099	$ 43

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity - Parenthetical - $ / shares	3 Months Ended	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Details
Common Stock, Dividends, Per Share, Declared	$ 0.15	$ 0.20	$ 0.15

Consolidated Statement of Cash

Consolidated Statement of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
CASH FLOWS PROVIDED BY (USED BY) OPERATING ACTIVITIES:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 15,806	$ 13,890
Net Cash Provided by (Used in) Operating Activities	29,739	6,436
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect	(12,531)	(5,704)
Adjustments to reconcile net income to net change in cash from
Deferred Policy Acquisition Costs, Amortization Expense	682	271
Gain (Loss) on Investments	1,626	(352)
Gain (Loss) on Disposition of Other Assets	3,589	0
Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net	646	0
Income (Loss) from Equity Method Investments	515	(765)
Depreciation, Depletion and Amortization, Nonproduction	1,598	1,271
Other Noncash Income (Expense)	(6,271)	(3,974)
Increase (Decrease) in Operating Capital
Increase (Decrease) in Insurance Liabilities	16,474	(6,954)
Increase (Decrease) in Premiums Receivable	602	3,665
Increase (Decrease) in Reinsurance Recoverable	(1,490)	(6,277)
Change in Claim Fund Balances	1,788	411
Increase (Decrease) in Other Operating Assets and Liabilities, Net	8,684	10,156
Net Cash Provided by (Used in) Investing Activities
Payments for (Proceeds from) Short-term Investments	(1,000)	0
Proceeds from (Payments for) Securities Purchased under Agreements to Resell	(26,801)	1,627
Proceeds from Sale of Debt and Equity Securities, FV-NI, Held-for-investment	0	698
Proceeds from Sale of Debt Securities, Available-for-sale	68,459	42,217
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale	43,034	8,727
Payments to Acquire Debt Securities, Available-for-sale	108,934	57,525
Payments to Acquire Businesses, Net of Cash Acquired	7,952	0
Proceeds from Sale, Maturity and Collection of Investments	5,117	0
Payments to Acquire Other Investments	3,000	0
Other investing activities	1,084	502
Net Cash Provided by (Used in) Investing Activities	(30,161)	(4,758)
Net Cash Provided by (Used in) Financing Activities
Payments for Repurchase of Common Stock	1,560	3,056
Net Change Annuities and Investment Certificates	(1,151)	(725)
Payments of Ordinary Dividends, Common Stock	2,242	3,710
Payments to Noncontrolling Interests	4,400	0
Proceeds from Stock Options Exercised	44	134
Payment, Tax Withholding, Share-based Payment Arrangement	2,397	0
Proceeds from (Payments for) Other Financing Activities	(403)	(25)
Net Cash Provided by (Used in) Financing Activities	(12,109)	(7,382)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Beginning Balance	30,807	32,197
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Ending Balance	$ 18,276	$ 26,493

Organization, Consolidation, Ba

Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]	6 Months Ended
	Jun. 30, 2019
Notes
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies	Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies (A) Business and Organization (B) Consolidation In May 2019, IHC purchased the remaining issued and outstanding units of HealthInsurance.org, LLC (“HIO”) from noncontrolling interests for total consideration valued at $4,700,000 making HIO a wholly owned subsidiary. The carrying value of the noncontrolling interest on the transaction date was $2,380,000. As a result of the equity transaction, $1,012,000 was charged to paid-in capital representing the difference between the fair value of the consideration paid and the carrying amount of noncontrolling interest on the transaction date, net of a deferred tax benefit. (C) Basis of Presentation The unaudited Condensed Consolidated Financial Statements have been prepared in conformity with U.S. generally accepted accounting principles ("GAAP") for interim financial statements and with the instructions to Form 10-Q and Article 10 of Regulation S-X and, therefore, do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements include the accounts of IHC and its consolidated subsidiaries. All significant intercompany transactions have been eliminated in consolidation. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect: (i) the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements; and (ii) the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. IHC’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission should be read in conjunction with the accompanying unaudited Condensed Consolidated Financial Statements. In the opinion of management, all adjustments (consisting only of normal recurring accruals) that are necessary for a fair presentation of the consolidated financial position and results of operations for the interim periods have been included. The condensed consolidated results of operations for the six months ended June 30, 2019 are not necessarily indicative of the results to be anticipated for the entire year. (D) Reclassifications Certain amounts in prior year’s consolidated financial statements and Notes thereto have been reclassified to conform to the 2019 presentation. (E) Revenue Recognition Insurance premiums are recognized as revenue over the period insurance protection is provided. For additional information about our policies regarding the recognition of premium revenues, see Note 1 of the Notes to Consolidated Financial Statements included in our 2018 Annual Report on Form 10-K as filed with the Securities and Exchange Commission. Fee income includes fees and commissions for various sales, marketing and administrative services provided by our marketing and administrative companies. Revenue is recognized as these services are performed. For these administrative service and other contracts, we have no material contract assets or contract liabilities on our consolidated balance sheet at June 30, 2019. Revenue recognized from performance obligations related to prior periods, and revenue expected to be recognized in future periods related to unfulfilled contractual performance obligations and contracts with variable consideration, is not material. (F) Recent Accounting Pronouncements Recently Adopted Accounting Standards In July 2018, the FASB issued guidance to simplify several aspects of accounting for nonemployee share-based compensation. The adoption of this guidance did not have a material effect on the Company’s consolidated financial statements. In March 2017, the FASB issued guidance requiring premium amortization on callable debt securities to be amortized to the earliest call date to more closely align the amortization period with expectations incorporated in market pricing of the underlying securities. The adoption of this guidance did not have a material effect on the Company’s consolidated financial statements. In February 2016, the FASB issued guidance that requires lessees to recognize the assets and liabilities that arise from leases, including operating leases, on the statement of financial position. The Company elected the following practical expedients permitted within the new standard:     The Company selected the new transition method by applying the new lease requirements on January 1, 2019, without adjustment to the financial statements for periods prior to adoption. As a result, on January 1, 2019, the Company recognized right-of-use assets of $7,010,000 for operating leases, reduced other liabilities by $687,000 to reclassify the unamortized balances of previously deferred operating lease incentives, and recognized operating lease liabilities of $7,697,000 in its Condensed Consolidated Balance Sheet. The adoption of this guidance did not have a material effect on the Company’s consolidated results of operations or cash flows. Recently Issued Accounting Standards Not Yet Adopted In October 2018, the FASB issued guidance for determining whether a decision making fee is a variable interest and requires reporting entities to consider indirect interests held through related parties under common control on a proportional basis rather than as the equivalent of a direct interest. The amendments in this guidance are effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The amendments in this guidance should be applied retrospectively through a cumulative effect adjustment to retained earnings at the beginning of the earliest period presented. The adoption of this guidance is not expected to have a material effect on the Company’s consolidated financial statements. In August 2018, the FASB issued guidance to improve existing measurements, presentation and disclosure requirements for long-duration contracts issued by insurance entities. The amendments in this guidance requires an entity to (1) review and update assumptions used to measure cash flows at least annually as well as update the discount rate assumption at each reporting date; (2) measure market risk benefits associated with deposit contracts at fair value; (3) disclose liability rollforwards and information about significant inputs, judgements assumptions, and methods used in measurement. Additionally, it simplifies the amortization of deferred acquisition costs and other balances on a constant level basis over the expected term of the related contracts. The amendments in this guidance are effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. Upon adoption, the amendments in this guidance should be applied to contracts in-force as of the beginning of the earliest period presented with a cumulative adjustment to beginning retained earnings. Management is evaluating the requirements and potential impact that the adoption of this guidance will have on the Company’s consolidated financial statements. In August 2018, the FASB issued guidance to improve the effectiveness of disclosures in the notes to financial statements regarding fair value measurements. The amendments in this guidance are effective for all entities for fiscal years beginning after December 15, 2019, including interim periods within that fiscal year. Certain amendments should be applied prospectively for the most recent interim or annual period presented in the initial fiscal year of adoption while other amendments should be applied retrospectively to all periods presented upon the effective date. The adoption of this guidance is not expected to have a material effect on the Company’s consolidated financial statements. In January 2017, the FASB issued guidance to simplify the test for goodwill impairment by eliminating Step 2 in the goodwill impairment test. Instead, under the amendments in this guidance, an entity should perform its annual or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. Additionally, an entity should consider income tax effects from any tax-deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. The amendments in this guidance are effective for public business entities for annual, or any interim, goodwill impairment tests in fiscal years beginning after December 15, 2019. The adoption of this guidance is not expected to have a material effect on the Company’s consolidated financial statements. In June 2016, the FASB issued guidance requiring financial assets measured at amortized cost basis to be presented at the net amount expected to be collected. An allowance for credit losses will be deducted from the amortized cost basis to present the net carrying value at the amount expected to be collected with changes in the allowance recorded in earnings. Credit losses relating to available-for-sale debt securities will also be recorded through an allowance for credit losses rather than the currently applied U.S. GAAP method of taking a permanent impairment of the security, which would be limited to the amount by which fair value is below the amortized cost. Certain existing requirements used to evaluate credit losses have been removed. In 2019, the FASB provided transition relief by providing entities with an option to irrevocably elect the fair value option on an instrument-by-instrument basis for eligible instruments upon adoption. For public entities that are SEC filers, the amendments in this guidance are effective for fiscal years beginning after December 15, 2019, including interim periods within those years. Early adoption is permitted for fiscal years beginning after December 15, 2018. The amendments in this guidance should be applied through a cumulative effect adjustment to retained earnings upon adoption as of the beginning of the first reporting period in which the guidance is effective. Management is evaluating the requirements and potential impact that the adoption of this guidance will have on the Company’s consolidated financial statements.

Earnings Per Share _Text Block_

Earnings Per Share [Text Block]	6 Months Ended
	Jun. 30, 2019
Notes
Earnings Per Share	Note 2. Income Per Common Share Diluted income per share was computed using the treasury stock method and includes incremental common shares, primarily from the dilutive effect of share-based payment awards, amounting to 19,000 and 68,000 shares for the three and six months ended June 30, 2019, respectively, and 329,000 and 286,000 shares for the three and six months ended June 30, 2018, respectively.

Cash and Cash Equivalents Discl

Cash and Cash Equivalents Disclosure	6 Months Ended
	Jun. 30, 2019
Notes
Cash and Cash Equivalents Disclosure	Note 3. Cash, Cash Equivalents and Restricted Cash June 30, 2019 2018 Cash and cash equivalents $ 14,982 $ 21,252 Restricted cash included in other assets 3,294 5,241 Total cash, cash equivalents and restricted cash $ 18,276 $ 26,493 Restricted cash includes insurance premiums collected from insureds that are pending remittance to insurance carriers and/or payment of insurance claims and commissions to third party administrators. These amounts are required to be set aside by contractual agreements with the insurance carriers and are included in other assets on the Condensed Consolidated Balance Sheets.

Investments in Debt and Marketa

Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]	6 Months Ended
	Jun. 30, 2019
Notes
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure	Note 4. Investment Securities The cost (amortized cost with respect to certain fixed maturities), gross unrealized gains, gross unrealized losses and fair value of fixed maturities available-for-sale are as follows for the periods indicated (in thousands): June 30, 2019 GROSS GROSS AMORTIZED UNREALIZED UNREALIZED FAIR COST GAINS LOSSES VALUE FIXED MATURITIES AVAILABLE-FOR-SALE: Corporate securities $ 234,938 $ 3,223 $ (1,361) $ 236,800 CMOs – residential (1) 5,745 10 (3) 5,752 U.S. Government obligations 31,829 253 (103) 31,979 GSEs (3) 6,414 - (111) 6,303 States and political subdivisions 166,727 1,785 (1,083) 167,429 Foreign government obligations 6,880 153 (6) 7,027 Redeemable preferred stocks 5,970 166 - 6,136 Total fixed maturities $ 458,503 $ 5,590 $ (2,667) $ 461,426 December 31, 2018 GROSS GROSS AMORTIZED UNREALIZED UNREALIZED FAIR COST GAINS LOSSES VALUE FIXED MATURITIES AVAILABLE-FOR-SALE: Corporate securities $ 202,194 $ 701 $ (5,406) $ 197,489 CMOs - residential (1) 6,092 - (252) 5,840 U.S. Government obligations 63,231 1 (423) 62,809 Agency MBS - residential (2) 3 - - 3 GSEs (3) 6,596 - (110) 6,486 States and political subdivisions 172,860 302 (5,228) 167,934 Foreign government obligations 7,039 51 (46) 7,044 Redeemable preferred stocks 5,970 - (111) 5,859 Total fixed maturities $ 463,985 $ 1,055 $ (11,576) $ 453,464 (1) (2) (3) The amortized cost and fair value of fixed maturities available-for-sale at June 30, 2019, by contractual maturity, are shown below (in thousands). Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. AMORTIZED FAIR COST VALUE Due in one year or less $ 39,315 $ 39,331 Due after one year through five years 168,512 170,281 Due after five years through ten years 162,244 164,144 Due after ten years 76,273 75,615 Fixed maturities with no single maturity date 12,159 12,055 $ 458,503 $ 461,426 The following tables summarize, for all fixed maturities available-for-sale in an unrealized loss position, the aggregate fair value and gross unrealized loss by length of time those securities that have continuously been in an unrealized loss position for the periods indicated (in thousands): June 30, 2019 Less than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses Corporate securities $ 7,307 $ 20 $ 57,300 $ 1,341 $ 64,607 $ 1,361 CMOs - residential - - 4,095 3 4,095 3 U.S. Government obligations 5,433 69 18,135 34 23,568 103 GSEs - - 6,297 111 6,297 111 States and political subdivisions 10,769 30 51,116 1,053 61,885 1,083 Foreign government obligations - - 1,659 6 1,659 6 Fixed maturities in an unrealized loss position $ 23,509 $ 119 $ 138,602 $ 2,548 $ 162,111 $ 2,667 Number of fixed maturities in an unrealized loss position 6 81 87 December 31, 2018 Less than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses Corporate securities $ 46,988 $ 1,045 $ 108,738 $ 4,361 $ 155,726 $ 5,406 CMOs - residential 847 37 4,993 215 5,840 252 U.S. Government obligations 6,138 15 31,693 408 37,831 423 GSEs - - 6,478 110 6,478 110 States and political subdivisions 33,021 522 113,297 4,706 146,318 5,228 Foreign government obligations - - 2,835 46 2,835 46 Redeemable preferred stocks 5,859 111 - - 5,859 111 Fixed maturities in an unrealized loss position $ 92,853 $ 1,730 $ 268,034 $ 9,846 $ 360,887 $ 11,576 Number of fixed maturities in an unrealized loss position 47 115 162 Substantially all of the unrealized losses on fixed maturities available-for-sale at June 30, 2019 and December 31, 2018 relate to investment grade securities and are attributable to changes in market interest rates. Because the Company does not intend to sell, nor is it more likely than not that the Company will have to sell such investments before recovery of their amortized cost bases, which may be maturity, the Company does not consider these investments to be other-than-temporarily impaired at June 30, 2019 Net investment gains (losses) are as follows for periods indicated (in thousands): Three Months Ended Six Months Ended June 30, June 30, 2019 2018 2019 2018 Realized gains (losses): Fixed maturities available-for-sale $ 1,271 $ (366) $ 1,249 $ (195) Equity securities - (5) - (5) Total realized gains (losses) on debt and equity securities 1,271 (371) 1,249 (200) Unrealized gains (losses) on equity securities 184 (52) 377 (152) Gains (losses) on debt and equity securities 1,455 (423) 1,626 (352) Gains (losses) on other investments - - - - Net investment gains (losses) $ 1,455 $ (423) $ 1,626 $ (352) For the three and six months ended June 30, 2019, the Company realized gross gains of $1,855,000 and $1,892,000, respectively, and gross losses of $584,000 and $643,000, respectively, from sales, maturities and prepayments of fixed maturities available-for-sale. For the three months and six months ended June 30, 2018, the company realized gross gains of $73,000 and $319,000, respectively, and gross losses of $439,000 and $514,000, respectively, from sales, maturities and prepayments of fixed maturities available for sale. Other-Than-Temporary Impairment Evaluations We recognize other-than-temporary impairment losses in earnings in the period that we determine: 1) we intend to sell the security; 2) it is more likely than not that we will be required to sell the security before recovery of its amortized cost basis; or 3) the security has a credit loss. Any non-credit portion of the other-than-temporary impairment loss is recognized in other comprehensive income (loss). See Note 1F(v) to the Consolidated Financial Statements in the 2018 Annual Report on Form 10-K for further discussion of the factors considered by management in its regular review to identify and recognize other-than-temporary impairments on fixed maturities available-for-sale. The Company recognized other-than-temporary impairment losses of $0 and $646,000 on certain fixed maturities available-for-sale securities in the three months and six months ended June 30, 2019, respectively. The Company determined that it was more likely than not that we would sell the securities before the recovery of their amortized cost basis. The Company did not recognize any other-than-temporary impairments on available for sale securities in the first six months of 2018.

Fair Value Disclosures _Text Bl

Fair Value Disclosures [Text Block]	6 Months Ended
	Jun. 30, 2019
Notes
Fair Value Disclosures	Note 5. Fair Value Disclosures For all financial and non-financial assets and liabilities accounted for at fair value on a recurring basis, the Company utilizes valuation techniques based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market expectations. These two types of inputs create the following fair value hierarchy: Level 1 Level 2 Level 3 The following section describes the valuation methodologies we use to measure different assets at fair value. Fixed maturities available-for-sale: Fixed maturities available-for-sale included in Level 2 are comprised of our portfolio of government securities, agency mortgage-backed securities, corporate fixed income securities, foreign government obligations, collateralized mortgage obligations, municipals and GSEs that were priced with observable market inputs. Level 3 debt securities consist of municipal tax credit strips. The valuation method used to determine the fair value of municipal tax credit strips is the present value of the remaining future tax credits (at the original issue discount rate) as presented in the redemption tables in the Municipal Prospectuses. This original issue discount is accreted into income on a constant yield basis over the term of the debt instrument. Further, we retain independent pricing vendors to assist in valuing certain instruments. Equity securities: The following tables present our financial assets measured at fair value on a recurring basis for the periods indicated (in thousands): June 30, 2019 Level 1 Level 2 Level 3 Total FINANCIAL ASSETS: Fixed maturities available-for-sale: Corporate securities $ - $ 236,800 $ - $ 236,800 CMOs - residential - 5,752 - 5,752 US Government obligations - 31,979 - 31,979 GSEs - 6,303 - 6,303 States and political subdivisions - 165,809 1,620 167,429 Foreign government obligations - 7,027 - 7,027 Redeemable preferred stocks 6,136 - - 6,136 Total fixed maturities 6,136 453,670 1,620 461,426 Equity securities: Common stocks 2,649 - - 2,649 Nonredeemable preferred stocks 2,894 - - 2,894 Total equity securities 5,543 - - 5,543 Total Financial Assets $ 11,679 $ 453,670 $ 1,620 $ 466,969 December 31, 2018 Level 1 Level 2 Level 3 Total FINANCIAL ASSETS: Fixed maturities available-for-sale: Corporate securities $ - $ 197,489 $ - $ 197,489 CMOs - residential - 5,840 - 5,840 US Government obligations - 62,809 - 62,809 Agency MBS - residential - 3 - 3 GSEs - 6,486 - 6,486 States and political subdivisions - 166,225 1,709 167,934 Foreign government obligations - 7,044 - 7,044 Redeemable preferred stocks 5,859 - - 5,859 Total fixed maturities 5,859 445,896 1,709 453,464 Equity securities: Common stocks 2,366 - - 2,366 Nonredeemable preferred stocks 2,800 - - 2,800 Total equity securities 5,166 - - 5,166 Total Financial Assets $ 11,025 $ 445,896 $ 1,709 $ 458,630 It is the Company’s policy to recognize transfers of assets and liabilities between levels of the fair value hierarchy at the end of a reporting period. The Company does not transfer out of Level 3 and into Level 2 until such time as observable inputs become available and reliable or the range of available independent prices narrow. The Company did not transfer any securities between Level 1, Level 2 or Level 3 in either 2019 or 2018. The following table presents the changes in fair value of our Level 3 financial assets for the periods indicated (in thousands): Three Months Ended June 30, 2019 2018 States and Total States and Total Political Level 3 Political Level 3 Subdivisions Assets Subdivisions Assets Beginning balance $ 1,664 $ 1,664 $ 1,836 $ 1,836 Increases (decreases) recognized in earnings: Net investment gains - - - - Gains (losses) included in other comprehensive income (loss): Net unrealized gains (losses) (6) (6) (8) (8) Repayments and amortization of fixed maturities (38) (38) (34) (34) Sales - - - - Balance at end of period $ 1,620 $ 1,620 $ 1,794 $ 1,794 Six Months Ended June 30, 2019 2018 States and Total States and Total Political Level 3 Political Level 3 Subdivisions Assets Subdivisions Assets Beginning balance $ 1,709 $ 1,709 $ 1,876 $ 1,876 Increases (decreases) recognized in earnings: Net investment gains - - - - Gains (losses) included in other comprehensive income (loss): Net unrealized gains (losses) (14) (14) (15) (15) Repayments and amortization of fixed maturities (75) (75) (67) (67) Sales - - - - Balance at end of period $ 1,620 $ 1,620 $ 1,794 $ 1,794 The following table provides carrying values, fair values and classification in the fair value hierarchy of the Company’s financial instruments, that are not carried at fair value but are subject to fair value disclosure requirements, for the periods indicated (in thousands): June 30, 2019 December 31, 2018 Level 1 Level 2 Level 1 Level 2 Fair Fair Carrying Fair Fair Carrying Value Value Value Value Value Value FINANCIAL ASSETS: Short-term investments $ 50 $ - $ 50 $ 1,050 $ - $ 1,050 FINANCIAL LIABILITIES: Funds on deposit $ - $ 141,539 $ 141,523 $ - $ 141,662 $ 141,635 Other policyholders’ funds - 11,757 11,757 - 10,939 10,939 The following methods and assumptions were used to estimate the fair value of the financial instruments that are not carried at fair value in the Condensed Consolidated Financial Statements: Short-term Investments Investments with original maturities of 91 days to one year are considered short-term investments and are carried at cost, which approximates fair value. Funds on Deposit The Company has two types of funds on deposit. The first type is credited with a current market interest rate, resulting in a fair value which approximates the carrying amount. The second type carries fixed interest rates which are higher than current market interest rates. The fair value of these deposits was estimated by discounting the payments using current market interest rates. The Company's universal life policies are also credited with current market interest rates, resulting in a fair value which approximates the carrying amount. Both types of funds on deposit are included in Level 2 of the fair value hierarchy. Other Policyholders’ Funds Other policyholders’ funds are primarily credited with current market interest rates resulting in a fair value which approximates the carrying amount.

Variable Interest Entity Disclo

Variable Interest Entity Disclosure [Text Block]	6 Months Ended
	Jun. 30, 2019
Notes
Variable Interest Entity Disclosure	Note 6. Other Investments, Including Variable Interest Entities Included in other investments is our investment in Ebix Health Exchange which administers various lines of health insurance for IHC’s insurance subsidiaries. The carrying value of the Company’s equity investment in Ebix Health Exchange is $4,762,000 and $6,425,000 at June 30, 2019 and December 31, 2018, respectively, and the Company recorded $(1,121,000) and $(1,663,000), respectively, of equity income (loss) from its investment for the three and six months ended June 30, 2019 and $(255,000) and $(771,000), respectively, of equity income (loss) from its investment for the same periods of 2018. At June 30, 2019 and December 31, 2018, the Company’s Condensed Consolidated Balance Sheets include $1,817,000 and $1,842,000, respectively, of notes and other amounts receivable from Ebix Health Exchange, and include $253,000 and $910,000, respectively, of administrative fees and other expenses payable to Ebix Health Exchange, which are included in other assets and accounts payable, accruals and other liabilities, respectively. The Company’s Condensed Consolidated Statements of Income include administrative fee expenses to Ebix Health Exchange, which are included in selling, general and administrative expenses of $525,000 and $987,000, for the three and six months ended June 30, 2019, respectively, and $1,926,000 and $4,473,000, respectively, for the same periods of 2018. In June 2019, the Company paid $3,000,000 for an equity interest in a lead generation company that will be accounted for as an equity method investment. In March 2019, the Company’s equity investment in Pets Best, that was carried at a cost of $500,000, was acquired by an unaffiliated entity and the Company realized a gain of $3,589,000 on the sale, which is included in Other Income in the Condensed Consolidated Statement of Income for the six months ended June 30, 2019. Variable Interest Entities The Company has a minority interest in certain limited partnerships that we have determined to be Variable Interest Entities (“VIEs”). The aforementioned VIEs are not required to be consolidated in the Company’s condensed consolidated financial statements as we are not the primary beneficiary since we do not have the power to direct the activities that most significantly impact the VIEs’ economic performance. The Company will periodically reassess whether we are the primary beneficiary in any of these investments. The reassessment process will consider whether we have acquired the power to direct the most significant activities of the VIE through changes in governing documents or other circumstances. Our maximum loss exposure is limited to our combined $6,524,000 carrying value in these equity investments which is included in other investments in the Condensed Consolidated Balance Sheet as of June 30, 2019.

BusinessCombinationAndDeconsoli

BusinessCombinationAndDeconsolidationDisclosure	6 Months Ended
	Jun. 30, 2019
Notes
BusinessCombinationAndDeconsolidationDisclosure	Note 7. Acquisitions In 2019 the Company made several business acquisitions as follows: In January 2019, the Company acquired all of the stock of My1HR, a web-based entity with a state-of-the-art insurance quoting and cloud-based enrollment platform. In general, companies that provide insurance through user-centric platforms, or create efficiencies in the insurance industry through technological advances, are referred to as “insuretech” companies. The Company acquired My1HR for its quoting and cloud-based enrollment platforms as part of an effort to expand our “insuretech” footprint through our agencies, which generate leads and sell our products through our owned call center and career advisors. In April 2019, the Company purchased substantially all of the assets and liabilities of a sales and customer service call center. The Company acquired the call center in order to capitalize on technology-driven trends in the purchase of health insurance directly by consumers. Prior to the purchase, the Company owned an equity interest in the call center. Immediately preceding the transaction, the Company determined the fair value of its equity interest to be $720,000 using a market approach and, as a result, recorded a loss of $237,000 which is included in other income on the Condensed Consolidated Statement of Income. The aggregate fair value of consideration transferred for these acquisitions was $8,534,000 cash. The following table presents the aggregate acquisition-date fair values of the identifiable assets acquired and liabilities assumed in these transactions (in thousands): Cash $ 582 Intangible assets 1,500 Other assets 1,301 Total identifiable assets 3,383 Other liabilities 3,637 Total liabilities 3,637 Net identifiable assets (liabilities) acquired $ (254) In connection with these acquisitions, the Company recorded $9,508,000 of goodwill and $1,500,000 of intangible assets (see Note 8). The fair value of the acquired identifiable intangible assets is provisional pending receipt of the final valuations for those assets and liabilities. The amount of goodwill and intangibles entitled to an amortization deduction for income tax purposes will be determined upon a mutually agreeable asset allocation of the acquisition consideration with the respective acquirees. Goodwill reflects the synergies with our insurance carriers. My1HR has an existing distribution network and offers increased distribution sources for IHC carrier products through its quoting and cloud based enrollment platforms designed specifically for producers in the small group employer market Acquisition-related costs, primarily legal and consulting fees, were not material and are included in selling, general and administrative expenses in the Consolidated Statement of Income. For the three months ended June 30, 2019, the Company’s Consolidated Statement of Income includes revenues and net income of $916,000 and $(406,000), respectively, from these acquisitions. For the period from the acquisition dates to June 30, 2019, the Company’s Consolidated Statement of Income includes revenues and net income of $1,424,000 and $(383,000), respectively, from these acquisitions. Pro forma adjustments to present the Company’s consolidated revenues and net income as if the acquisition dates were January 1, 2018 are not material and accordingly are omitted.

Goodwill and Intangible Assets

Goodwill and Intangible Assets Disclosure [Text Block]	6 Months Ended
	Jun. 30, 2019
Notes
Goodwill and Intangible Assets Disclosure	Note 8. Goodwill and Other Intangible Assets June 30, 2019 December 31, 2018 Gross Gross Carrying Accumulated Carrying Accumulated Amount Amortization Amount Amortization Finite-lived Intangible Assets: Agent and broker relationships $ 18,753 $ 13,971 $ 17,253 $ 13,419 Domain 1,000 275 1,000 225 Software systems 780 269 780 203 Total finite-lived $ 20,533 $ 14,515 $ 19,033 $ 13,847 June 30, December 31, 2019 2018 Indefinite-lived Intangible Assets: Insurance licenses $ 7,977 $ 7,977 Total indefinite-lived $ 7,977 $ 7,977 As discussed in Note 7, in connection with business acquisitions in 2019, the Company recorded $9,508,000 of goodwill and $1,500,000 of intangible assets associated with the Specialty Health segment. The intangible assets primarily represent the fair value of customer relationships and are being amortized over a weighted average period of 17 years.

Income Tax Disclosure _Text Blo

Income Tax Disclosure [Text Block]	6 Months Ended
	Jun. 30, 2019
Notes
Income Tax Disclosure	Note 9. Income Taxes The provisions for income taxes shown in the Condensed Consolidated Statements of Income were computed by applying the effective tax rate expected to be applicable for the reporting periods. In 2017, the Tax Cuts and Jobs Act (the “Tax Act”) was enacted. The Tax Act makes broad and complex changes to the U.S. tax code, including, but not limited to, reducing the Federal corporate income tax rate to 21% effective January 1, 2018. As a result of IHC’s June 30 fiscal tax year, the Tax Act subjects IHC to a blended tax rate of 28% for its fiscal tax year ended June 30, 2018. Other differences between the Federal statutory income tax rate and the Company’s effective income tax rate are principally from the dividends received deduction and tax exempt interest income, state and local income taxes, and compensation related tax provisions. The Internal Revenue Service has completed its review of the Company’s 2015 consolidated income tax return with no changes in the Company’s reported tax, however, the New York State Department of Taxation and Finance has recently selected the Company’s 2015 and 2016 income tax returns for audit.

Lessee, Operating Leases

Lessee, Operating Leases	6 Months Ended
	Jun. 30, 2019
Notes
Lessee, Operating Leases	Note 10. Leases Certain subsidiaries of the Company are obligated under operating lease agreements for office space and office equipment. Three Months Six Months Ended Ended June 30, 2019 June 30, 2019 Operating lease costs $ 575 $ 1,111 Short-term lease costs 50 74 Variable lease costs 132 206 Total lease costs $ 757 $ 1,391 Other information: Operating cash flows from operating leases $ (568) $ (1,173) Right-of-use assets obtained for operating leases $ 583 $ 639 Due in the next year $ 2,339 Due in two years 1,845 Due in three years 1,608 Due in four years 1,113 Due in five years 486 Due in remaining years 1,321 Total payments due 8,712 Present value discount (1,295) Operating lease liability $ 7,417

Liability for Future Policy Ben

Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]	6 Months Ended
	Jun. 30, 2019
Notes
Liability for Future Policy Benefits and Unpaid Claims Disclosure	Note 11. Policy Benefits and Claims Policy benefits and claims is the liability for unpaid loss and loss adjustment expenses. It is comprised of unpaid claims and estimated incurred but not reported (“IBNR”) reserves. Summarized below are the changes in the total liability for policy benefits and claims for the periods indicated (in thousands). Six Months Ended June 30, 2019 2018 Balance at beginning of year $ 160,115 $ 168,683 Less: reinsurance recoverable 38,122 42,136 Net balance at beginning of year 121,993 126,547 Amount incurred, related to: Current year 96,736 84,871 Prior years (8,141) (13,189) Total incurred 88,595 71,682 Amount paid, related to: Current year 41,644 35,956 Prior years 37,242 42,108 Total paid 78,886 78,064 Net balance at end of year 131,702 120,165 Plus: reinsurance recoverable 37,282 39,513 Balance at end of year $ 168,984 $ 159,678 Since unpaid loss and loss adjustment expenses are estimates, actual losses incurred may be more or less than the Company’s previously developed estimates and is referred to as either unfavorable or favorable development, respectively. The overall net favorable development of $8,141,000 in 2019 related to prior years consists of favorable developments of $3,158,000 in Specialty Health reserves, $4,230,000 in the group disability reserves, $594,000 in the other individual life, annuities and other reserves, and $159,000 in Medical Stop-Loss reserves. Specialty Health net favorable development occurred primarily in the pets, fixed indemnity limited benefit, short-term medical and occupational accident lines of business. Group Disability net favorable development was primarily due to favorable claim experience in the DBL and LTD lines of business. The overall net favorable development of $13,189,000 in 2018 related to prior years primarily consists of favorable developments of $8,398,000 in the Specialty Health reserves, $3,345,000 in the group disability reserves, $998,000 in the other individual life, annuities and other reserves, and $448,000 in Medical Stop-Loss reserves. Included in the preceding rollforward of the Company’s liability for policy benefits and claims are the policy benefits and claims activity associated with the Company’s health insurance lines. These are embedded within the Specialty Health segment. The table below summarizes the components of the change in the liability for policy benefits and claims that are specific to health insurance claims for the periods indicated (in thousands). Specialty Health Segment Health Insurance Claims Six Months Ended June 30, 2019 2018 Balance at beginning of year $ 26,068 $ 32,904 Less: reinsurance recoverable 851 762 Net balance at beginning of year 25,217 32,142 Amount incurred, related to: Current year 25,855 26,747 Prior years (1,622) (7,174) Total incurred 24,233 19,573 Amount paid, related to: Current year 7,838 7,336 Prior years 13,157 16,662 Total paid 20,995 23,998 Net balance at end of year 28,455 27,717 Plus: reinsurance recoverable 445 683 Balance at end of year $ 28,900 $ 28,400 The liability for the IBNR plus expected development on reported claims associated with the Company’s health insurance claims is $28,455,000 at June 30, 2019.

Stockholders' Equity Note Discl

Stockholders' Equity Note Disclosure [Text Block]	6 Months Ended
	Jun. 30, 2019
Notes
Stockholders' Equity Note Disclosure	Note 12. Stockholders’ Equity Accumulated Other Comprehensive Income (Loss) Other comprehensive income (loss) includes the after-tax net unrealized gains and losses on investment securities available-for-sale, including the subsequent increases and decreases in fair value of available-for-sale securities previously impaired and the non-credit related component of other-than-temporary impairments of fixed maturities. Changes in the balances of accumulated other comprehensive income, shown net of taxes, for the periods indicated are as follows (in thousands): Three Months Ended Six Months Ended June 30, June 30, 2019 2018 2019 2018 Beginning balance $ (2,641) $ (8,985) $ (8,310) $ (4,598) Cumulative-effect of new accounting principles - - - (350) Other comprehensive income (loss): Other comprehensive income (loss) before reclassifications 5,935 (2,541) 11,077 (6,442) Amounts reclassified from accumulated OCI (996) 289 (469) 153 Net other comprehensive income 4,939 (2,252) 10,608 (6,289) Ending balance $ 2,298 $ (11,237) $ 2,298 $ (11,237) Presented below are the amounts reclassified out of accumulated other comprehensive income (loss) and recognized in earnings for each of the periods indicated (in thousands): Three Months Ended Six Months Ended June 30, June 30, 2019 2018 2019 2018 Unrealized gains (losses) on available-for-sale securities reclassified during the period to the following income statement line items: Net investment gains (losses) $ 1,271 $ (366) $ 1,249 $ (195) Net impairment losses recognized in earnings - - (646) - Income (loss) before income tax 1,271 (366) 603 (195) Tax effect 275 (77) 134 (42) Net income (loss) $ 996 $ (289) $ 469 $ (153)

Compensation and Employee Benef

Compensation and Employee Benefit Plans [Text Block]	6 Months Ended
	Jun. 30, 2019
Notes
Compensation and Employee Benefit Plans	Note 13. Share-Based Compensation IHC stock option activity during the first six months of 2019 was as follows: Shares Weighted- Average Under Option Exercise Price December 31, 2018 567,384 $ 19.40 Granted 424,380 37.38 Exercised (192,050) 9.34 Forfeited (4,000) 22.20 June 30, 2019 795,714 $ 31.40 In 2019, IHC received $44,000 in cash from the exercise of stock options with an aggregate intrinsic value of $5,002,000 and recognized $737,000 of tax benefits. Cash outflows in 2019 to satisfy employees’ income tax withholding obligations amounted to $2,397,000.

Cash Flow, Supplemental Disclos

Cash Flow, Supplemental Disclosures [Text Block]	6 Months Ended
	Jun. 30, 2019
Notes
Cash Flow, Supplemental Disclosures	Note 14. Supplemental Disclosures of Cash Flow Information Net cash payments for income taxes were $388,000 and $1,104,000 during the six months ended June 30, 2019 and 2018, respectively.

Commitments and Contingencies D

Commitments and Contingencies Disclosure [Text Block]	6 Months Ended
	Jun. 30, 2019
Notes
Commitments and Contingencies Disclosure	Note 15. Contingencies Third Party Administrator A third party administrator with whom we formerly did business (“Plaintiff” or “TPA”)) filed a Complaint dated May 17, 2017 in the United States District Court, Northern District of Texas, Dallas Division, naming IHC, Madison National Life, Standard Security Life, and IHC Carrier Solutions, Inc. (collectively referred to as “Defendants”). “Plaintiff” and “Defendants” are collectively referred to herein as the “Parties”. The Complaint concerns agreements entered into by Standard Security Life and Madison National Life with Plaintiff, as well as other allegations made by Plaintiff against Defendants. The Complaint seeks injunctive relief and damages in an amount exceeding $50,000,000, payments allegedly owed to Plaintiff under the agreements totaling at least $3,082,000 through 2014, plus additional amounts for 2015 and 2016, and exemplary and punitive damages as allowed by law and fees and costs. Defendants believe these claims to be without merit. Defendants moved to Compel Arbitration and Dismiss or Stay the original Complaint. Plaintiff filed an Amended Complaint on August 18, 2017. Defendants filed a Motion to Compel Arbitration or Stay the Amended Complaint. The Parties agreed to enter into an Order staying the action filed in Texas. The Parties’ disputed claims moved in part to arbitration. Standard Security Life and Madison National Life demanded arbitration against this TPA. The Arbitration Panel issued an Order splitting the hearing into two phases. Standard Security Life and Madison National Life successfully presented their claims in Phase I on September 25 through September 28, 2018. The TPA’s counterclaims were heard during Phase II held on February 11, 2019 through February 15, 2019. Standard Security Life and Madison National Life successfully opposed the counterclaims asserted by the TPA as the Arbitration Panel denied all claims against Standard Security Life and Madison National Life. Since the arbitration is complete, the stay in the Texas litigation has been lifted. Defendants filed a Motion to Dismiss. Multistate Market Conduct Examination As previously disclosed, our subsidiaries, Standard Security Life, Madison National Life and Independence American, have been selected for a multistate market conduct exam ("MCE") related to our short term medical, limited medical and fixed indemnity health insurance products for the period of January 1, 2014 through September 30, 2017. The insurance departments of five jurisdictions (Delaware, Wisconsin, District of Columbia, Kansas and South Dakota) are serving as leads, and the District of Columbia Department of Insurance, Securities and Banking and the Delaware Department of Insurance are serving as the managing lead states of the MCE. In addition to these five, 36 other states are participating in the exam. Each of our subsidiaries separately responded to inquiries and document production requests in this matter, and has proactively communicated and cooperated with all applicable regulatory agencies. Each of our subsidiaries has also provided a detailed action plan to regulators that summarizes its newly developed and enhanced compliance and control mechanisms. On July 18, 2019, each of our subsidiaries received a proposed Regulatory Settlement Agreement ("RSA") to resolve the MCE with respect to such company. The proposed RSAs provide for monetary penalties as well as requirements related to our subsidiaries' marketing activities and periodic reporting to regulators. Standard Security Life, Madison National Life and Independence American are in the process of evaluating the proposed RSAs and anticipate entering into confidential discussions with the insurance departments of the lead jurisdictions in the coming weeks. At this time, the Company is not able to reasonably estimate any settlement amount or range of settlement amounts that may result from such discussions.

Segment Reporting Disclosure _T

Segment Reporting Disclosure [Text Block]	6 Months Ended
	Jun. 30, 2019
Notes
Segment Reporting Disclosure	Note 16. Segment Reporting The Insurance Group principally engages in the life and health insurance business. Interest expense, taxes, and general expenses associated with parent company activities are included in Corporate. Identifiable assets by segment are those assets that are utilized in each segment and are allocated based upon the mean reserves and liabilities of each such segment. Corporate assets are composed principally of cash equivalents, resale agreements, fixed maturities, equity securities, partnership interests and certain other investments. Information by business segment is presented below for the periods indicated (in thousands): Three Months Ended Six Months Ended June 30, June 30, 2019 2018 2019 2018 Revenues: Specialty Health $ 47,743 $ 49,087 $ 101,182 $ 99,851 Group disability, life, DBL and PFL 42,914 35,222 83,043 71,681 Individual life, annuities and other (A) 404 445 822 912 Medical Stop-Loss (A) 2 11 4 23 Corporate 2,604 546 3,273 1,077 93,667 85,311 188,324 173,544 Net investment gains (losses) 1,455 (423) 1,626 (352) Net impairment losses recognized in earnings - - (646) - Total revenues $ 95,122 $ 84,888 $ 189,304 $ 173,192 Income before income taxes Specialty Health (B) $ 2,823 $ 7,255 $ 12,481 $ 12,724 Group disability, life, DBL and PFL 5,038 4,699 9,202 10,645 Individual life, annuities and other (A) (C) (314) (126) (767) (294) Medical Stop-Loss (A) 213 70 285 164 Corporate (709) (1,981) (3,141) (4,339) 7,051 9,917 18,060 18,900 Net investment gains (losses) 1,455 (423) 1,626 (352) Net impairment losses recognized in earnings - (646) - Income before income taxes $ 8,506 $ 9,494 $ 19,040 $ 18,548 (A) (B) (C)

Organization, Consolidation, _2

Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]: Basis of Accounting, Policy [Policy Text Block] (Policies)	6 Months Ended
	Jun. 30, 2019
Policies
Basis of Accounting, Policy	The unaudited Condensed Consolidated Financial Statements have been prepared in conformity with U.S. generally accepted accounting principles ("GAAP") for interim financial statements and with the instructions to Form 10-Q and Article 10 of Regulation S-X and, therefore, do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements include the accounts of IHC and its consolidated subsidiaries. All significant intercompany transactions have been eliminated in consolidation. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect: (i) the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements; and (ii) the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. IHC’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission should be read in conjunction with the accompanying unaudited Condensed Consolidated Financial Statements. In the opinion of management, all adjustments (consisting only of normal recurring accruals) that are necessary for a fair presentation of the consolidated financial position and results of operations for the interim periods have been included. The condensed consolidated results of operations for the six months ended June 30, 2019 are not necessarily indicative of the results to be anticipated for the entire year.

Organization, Consolidation, _3

Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]: Reclassification, Policy [Policy Text Block] (Policies)	6 Months Ended
	Jun. 30, 2019
Policies
Reclassification, Policy	Certain amounts in prior year’s consolidated financial statements and Notes thereto have been reclassified to conform to the 2019 presentation.

Organization, Consolidation, _4

Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]: Revenue (Policies)	6 Months Ended
	Jun. 30, 2019
Policies
Revenue

Organization, Consolidation, _5

Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]: New Accounting Pronouncements, Policy [Policy Text Block] (Policies)	6 Months Ended
	Jun. 30, 2019
Policies
New Accounting Pronouncements, Policy	Recently Adopted Accounting Standards In July 2018, the FASB issued guidance to simplify several aspects of accounting for nonemployee share-based compensation. The adoption of this guidance did not have a material effect on the Company’s consolidated financial statements. In March 2017, the FASB issued guidance requiring premium amortization on callable debt securities to be amortized to the earliest call date to more closely align the amortization period with expectations incorporated in market pricing of the underlying securities. The adoption of this guidance did not have a material effect on the Company’s consolidated financial statements. In February 2016, the FASB issued guidance that requires lessees to recognize the assets and liabilities that arise from leases, including operating leases, on the statement of financial position. The Company elected the following practical expedients permitted within the new standard:     The Company selected the new transition method by applying the new lease requirements on January 1, 2019, without adjustment to the financial statements for periods prior to adoption. As a result, on January 1, 2019, the Company recognized right-of-use assets of $7,010,000 for operating leases, reduced other liabilities by $687,000 to reclassify the unamortized balances of previously deferred operating lease incentives, and recognized operating lease liabilities of $7,697,000 in its Condensed Consolidated Balance Sheet. The adoption of this guidance did not have a material effect on the Company’s consolidated results of operations or cash flows. Recently Issued Accounting Standards Not Yet Adopted In October 2018, the FASB issued guidance for determining whether a decision making fee is a variable interest and requires reporting entities to consider indirect interests held through related parties under common control on a proportional basis rather than as the equivalent of a direct interest. The amendments in this guidance are effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The amendments in this guidance should be applied retrospectively through a cumulative effect adjustment to retained earnings at the beginning of the earliest period presented. The adoption of this guidance is not expected to have a material effect on the Company’s consolidated financial statements. In August 2018, the FASB issued guidance to improve existing measurements, presentation and disclosure requirements for long-duration contracts issued by insurance entities. The amendments in this guidance requires an entity to (1) review and update assumptions used to measure cash flows at least annually as well as update the discount rate assumption at each reporting date; (2) measure market risk benefits associated with deposit contracts at fair value; (3) disclose liability rollforwards and information about significant inputs, judgements assumptions, and methods used in measurement. Additionally, it simplifies the amortization of deferred acquisition costs and other balances on a constant level basis over the expected term of the related contracts. The amendments in this guidance are effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. Upon adoption, the amendments in this guidance should be applied to contracts in-force as of the beginning of the earliest period presented with a cumulative adjustment to beginning retained earnings. Management is evaluating the requirements and potential impact that the adoption of this guidance will have on the Company’s consolidated financial statements. In August 2018, the FASB issued guidance to improve the effectiveness of disclosures in the notes to financial statements regarding fair value measurements. The amendments in this guidance are effective for all entities for fiscal years beginning after December 15, 2019, including interim periods within that fiscal year. Certain amendments should be applied prospectively for the most recent interim or annual period presented in the initial fiscal year of adoption while other amendments should be applied retrospectively to all periods presented upon the effective date. The adoption of this guidance is not expected to have a material effect on the Company’s consolidated financial statements. In January 2017, the FASB issued guidance to simplify the test for goodwill impairment by eliminating Step 2 in the goodwill impairment test. Instead, under the amendments in this guidance, an entity should perform its annual or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. Additionally, an entity should consider income tax effects from any tax-deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. The amendments in this guidance are effective for public business entities for annual, or any interim, goodwill impairment tests in fiscal years beginning after December 15, 2019. The adoption of this guidance is not expected to have a material effect on the Company’s consolidated financial statements. In June 2016, the FASB issued guidance requiring financial assets measured at amortized cost basis to be presented at the net amount expected to be collected. An allowance for credit losses will be deducted from the amortized cost basis to present the net carrying value at the amount expected to be collected with changes in the allowance recorded in earnings. Credit losses relating to available-for-sale debt securities will also be recorded through an allowance for credit losses rather than the currently applied U.S. GAAP method of taking a permanent impairment of the security, which would be limited to the amount by which fair value is below the amortized cost. Certain existing requirements used to evaluate credit losses have been removed. In 2019, the FASB provided transition relief by providing entities with an option to irrevocably elect the fair value option on an instrument-by-instrument basis for eligible instruments upon adoption. For public entities that are SEC filers, the amendments in this guidance are effective for fiscal years beginning after December 15, 2019, including interim periods within those years. Early adoption is permitted for fiscal years beginning after December 15, 2018. The amendments in this guidance should be applied through a cumulative effect adjustment to retained earnings upon adoption as of the beginning of the first reporting period in which the guidance is effective. Management is evaluating the requirements and potential impact that the adoption of this guidance will have on the Company’s consolidated financial statements.

Fair Value Disclosures _Text _2

Fair Value Disclosures [Text Block]: Fair Value Transfer, Policy (Policies)	6 Months Ended
	Jun. 30, 2019
Policies
Fair Value Transfer, Policy	It is the Company’s policy to recognize transfers of assets and liabilities between levels of the fair value hierarchy at the end of a reporting period. The Company does not transfer out of Level 3 and into Level 2 until such time as observable inputs become available and reliable or the range of available independent prices narrow. The Company did not transfer any securities between Level 1, Level 2 or Level 3 in either 2019 or 2018.

Cash and Cash Equivalents Dis_2

Cash and Cash Equivalents Disclosure: Schedule of Cash and Cash Equivalents (Tables)	6 Months Ended
	Jun. 30, 2019
Tables/Schedules
Schedule of Cash and Cash Equivalents	June 30, 2019 2018 Cash and cash equivalents $ 14,982 $ 21,252 Restricted cash included in other assets 3,294 5,241 Total cash, cash equivalents and restricted cash $ 18,276 $ 26,493

Investments in Debt and Marke_2

Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Debt Securities, Available-for-sale [Table Text Block] (Tables)	6 Months Ended
	Jun. 30, 2019
Tables/Schedules
Debt Securities, Available-for-sale	June 30, 2019 GROSS GROSS AMORTIZED UNREALIZED UNREALIZED FAIR COST GAINS LOSSES VALUE FIXED MATURITIES AVAILABLE-FOR-SALE: Corporate securities $ 234,938 $ 3,223 $ (1,361) $ 236,800 CMOs – residential (1) 5,745 10 (3) 5,752 U.S. Government obligations 31,829 253 (103) 31,979 GSEs (3) 6,414 - (111) 6,303 States and political subdivisions 166,727 1,785 (1,083) 167,429 Foreign government obligations 6,880 153 (6) 7,027 Redeemable preferred stocks 5,970 166 - 6,136 Total fixed maturities $ 458,503 $ 5,590 $ (2,667) $ 461,426 December 31, 2018 GROSS GROSS AMORTIZED UNREALIZED UNREALIZED FAIR COST GAINS LOSSES VALUE FIXED MATURITIES AVAILABLE-FOR-SALE: Corporate securities $ 202,194 $ 701 $ (5,406) $ 197,489 CMOs - residential (1) 6,092 - (252) 5,840 U.S. Government obligations 63,231 1 (423) 62,809 Agency MBS - residential (2) 3 - - 3 GSEs (3) 6,596 - (110) 6,486 States and political subdivisions 172,860 302 (5,228) 167,934 Foreign government obligations 7,039 51 (46) 7,044 Redeemable preferred stocks 5,970 - (111) 5,859 Total fixed maturities $ 463,985 $ 1,055 $ (11,576) $ 453,464 (1) (2) (3)

Investments in Debt and Marke_3

Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Investments Classified by Contractual Maturity Date (Tables)	6 Months Ended
	Jun. 30, 2019
Tables/Schedules
Investments Classified by Contractual Maturity Date	AMORTIZED FAIR COST VALUE Due in one year or less $ 39,315 $ 39,331 Due after one year through five years 168,512 170,281 Due after five years through ten years 162,244 164,144 Due after ten years 76,273 75,615 Fixed maturities with no single maturity date 12,159 12,055 $ 458,503 $ 461,426

Investments in Debt and Marke_4

Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value (Tables)	6 Months Ended
	Jun. 30, 2019
Tables/Schedules
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	June 30, 2019 Less than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses Corporate securities $ 7,307 $ 20 $ 57,300 $ 1,341 $ 64,607 $ 1,361 CMOs - residential - - 4,095 3 4,095 3 U.S. Government obligations 5,433 69 18,135 34 23,568 103 GSEs - - 6,297 111 6,297 111 States and political subdivisions 10,769 30 51,116 1,053 61,885 1,083 Foreign government obligations - - 1,659 6 1,659 6 Fixed maturities in an unrealized loss position $ 23,509 $ 119 $ 138,602 $ 2,548 $ 162,111 $ 2,667 Number of fixed maturities in an unrealized loss position 6 81 87 December 31, 2018 Less than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses Corporate securities $ 46,988 $ 1,045 $ 108,738 $ 4,361 $ 155,726 $ 5,406 CMOs - residential 847 37 4,993 215 5,840 252 U.S. Government obligations 6,138 15 31,693 408 37,831 423 GSEs - - 6,478 110 6,478 110 States and political subdivisions 33,021 522 113,297 4,706 146,318 5,228 Foreign government obligations - - 2,835 46 2,835 46 Redeemable preferred stocks 5,859 111 - - 5,859 111 Fixed maturities in an unrealized loss position $ 92,853 $ 1,730 $ 268,034 $ 9,846 $ 360,887 $ 11,576 Number of fixed maturities in an unrealized loss position 47 115 162

Investments in Debt and Marke_5

Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Realized Gain (Loss) on Investments (Tables)	6 Months Ended
	Jun. 30, 2019
Tables/Schedules
Realized Gain (Loss) on Investments	Three Months Ended Six Months Ended June 30, June 30, 2019 2018 2019 2018 Realized gains (losses): Fixed maturities available-for-sale $ 1,271 $ (366) $ 1,249 $ (195) Equity securities - (5) - (5) Total realized gains (losses) on debt and equity securities 1,271 (371) 1,249 (200) Unrealized gains (losses) on equity securities 184 (52) 377 (152) Gains (losses) on debt and equity securities 1,455 (423) 1,626 (352) Gains (losses) on other investments - - - - Net investment gains (losses) $ 1,455 $ (423) $ 1,626 $ (352)

Fair Value Disclosures _Text _3

Fair Value Disclosures [Text Block]: Fair Value, Assets Measured on Recurring Basis (Tables)	6 Months Ended
	Jun. 30, 2019
Tables/Schedules
Fair Value, Assets Measured on Recurring Basis	June 30, 2019 Level 1 Level 2 Level 3 Total FINANCIAL ASSETS: Fixed maturities available-for-sale: Corporate securities $ - $ 236,800 $ - $ 236,800 CMOs - residential - 5,752 - 5,752 US Government obligations - 31,979 - 31,979 GSEs - 6,303 - 6,303 States and political subdivisions - 165,809 1,620 167,429 Foreign government obligations - 7,027 - 7,027 Redeemable preferred stocks 6,136 - - 6,136 Total fixed maturities 6,136 453,670 1,620 461,426 Equity securities: Common stocks 2,649 - - 2,649 Nonredeemable preferred stocks 2,894 - - 2,894 Total equity securities 5,543 - - 5,543 Total Financial Assets $ 11,679 $ 453,670 $ 1,620 $ 466,969 December 31, 2018 Level 1 Level 2 Level 3 Total FINANCIAL ASSETS: Fixed maturities available-for-sale: Corporate securities $ - $ 197,489 $ - $ 197,489 CMOs - residential - 5,840 - 5,840 US Government obligations - 62,809 - 62,809 Agency MBS - residential - 3 - 3 GSEs - 6,486 - 6,486 States and political subdivisions - 166,225 1,709 167,934 Foreign government obligations - 7,044 - 7,044 Redeemable preferred stocks 5,859 - - 5,859 Total fixed maturities 5,859 445,896 1,709 453,464 Equity securities: Common stocks 2,366 - - 2,366 Nonredeemable preferred stocks 2,800 - - 2,800 Total equity securities 5,166 - - 5,166 Total Financial Assets $ 11,025 $ 445,896 $ 1,709 $ 458,630

Fair Value Disclosures _Text _4

Fair Value Disclosures [Text Block]: Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation (Tables)	6 Months Ended
	Jun. 30, 2019
Tables/Schedules
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation	Three Months Ended June 30, 2019 2018 States and Total States and Total Political Level 3 Political Level 3 Subdivisions Assets Subdivisions Assets Beginning balance $ 1,664 $ 1,664 $ 1,836 $ 1,836 Increases (decreases) recognized in earnings: Net investment gains - - - - Gains (losses) included in other comprehensive income (loss): Net unrealized gains (losses) (6) (6) (8) (8) Repayments and amortization of fixed maturities (38) (38) (34) (34) Sales - - - - Balance at end of period $ 1,620 $ 1,620 $ 1,794 $ 1,794 Six Months Ended June 30, 2019 2018 States and Total States and Total Political Level 3 Political Level 3 Subdivisions Assets Subdivisions Assets Beginning balance $ 1,709 $ 1,709 $ 1,876 $ 1,876 Increases (decreases) recognized in earnings: Net investment gains - - - - Gains (losses) included in other comprehensive income (loss): Net unrealized gains (losses) (14) (14) (15) (15) Repayments and amortization of fixed maturities (75) (75) (67) (67) Sales - - - - Balance at end of period $ 1,620 $ 1,620 $ 1,794 $ 1,794

Fair Value Disclosures _Text _5

Fair Value Disclosures [Text Block]: Fair Value, by Balance Sheet Grouping (Tables)	6 Months Ended
	Jun. 30, 2019
Tables/Schedules
Fair Value, by Balance Sheet Grouping	June 30, 2019 December 31, 2018 Level 1 Level 2 Level 1 Level 2 Fair Fair Carrying Fair Fair Carrying Value Value Value Value Value Value FINANCIAL ASSETS: Short-term investments $ 50 $ - $ 50 $ 1,050 $ - $ 1,050 FINANCIAL LIABILITIES: Funds on deposit $ - $ 141,539 $ 141,523 $ - $ 141,662 $ 141,635 Other policyholders’ funds - 11,757 11,757 - 10,939 10,939

BusinessCombinationAndDeconso_2

BusinessCombinationAndDeconsolidationDisclosure: Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Tables)	6 Months Ended
	Jun. 30, 2019
Series of Individually Immaterial Business Acquisitions
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	Cash $ 582 Intangible assets 1,500 Other assets 1,301 Total identifiable assets 3,383 Other liabilities 3,637 Total liabilities 3,637 Net identifiable assets (liabilities) acquired $ (254)

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets Disclosure [Text Block]: Schedule of Finite-Lived Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2019
Tables/Schedules
Schedule of Finite-Lived Intangible Assets	June 30, 2019 December 31, 2018 Gross Gross Carrying Accumulated Carrying Accumulated Amount Amortization Amount Amortization Finite-lived Intangible Assets: Agent and broker relationships $ 18,753 $ 13,971 $ 17,253 $ 13,419 Domain 1,000 275 1,000 225 Software systems 780 269 780 203 Total finite-lived $ 20,533 $ 14,515 $ 19,033 $ 13,847

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets Disclosure [Text Block]: Schedule of Indefinite-Lived Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2019
Tables/Schedules
Schedule of Indefinite-Lived Intangible Assets	June 30, December 31, 2019 2018 Indefinite-lived Intangible Assets: Insurance licenses $ 7,977 $ 7,977 Total indefinite-lived $ 7,977 $ 7,977

Lessee, Operating Leases_ Lease

Lessee, Operating Leases: Lease, Cost (Tables)	6 Months Ended
	Jun. 30, 2019
Tables/Schedules
Lease, Cost	Three Months Six Months Ended Ended June 30, 2019 June 30, 2019 Operating lease costs $ 575 $ 1,111 Short-term lease costs 50 74 Variable lease costs 132 206 Total lease costs $ 757 $ 1,391 Other information: Operating cash flows from operating leases $ (568) $ (1,173) Right-of-use assets obtained for operating leases $ 583 $ 639

Lessee, Operating Leases_ Lesse

Lessee, Operating Leases: Lessee, Operating Lease, Liability, Maturity (Tables)	6 Months Ended
	Jun. 30, 2019
Tables/Schedules
Lessee, Operating Lease, Liability, Maturity	Due in the next year $ 2,339 Due in two years 1,845 Due in three years 1,608 Due in four years 1,113 Due in five years 486 Due in remaining years 1,321 Total payments due 8,712 Present value discount (1,295) Operating lease liability $ 7,417

Liability for Future Policy B_2

Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]: Schedule of Liability for Unpaid Claims and Claims Adjustment Expense (Tables)	6 Months Ended
	Jun. 30, 2019
Schedule of Liability for Unpaid Claims and Claims Adjustment Expense	Six Months Ended June 30, 2019 2018 Balance at beginning of year $ 160,115 $ 168,683 Less: reinsurance recoverable 38,122 42,136 Net balance at beginning of year 121,993 126,547 Amount incurred, related to: Current year 96,736 84,871 Prior years (8,141) (13,189) Total incurred 88,595 71,682 Amount paid, related to: Current year 41,644 35,956 Prior years 37,242 42,108 Total paid 78,886 78,064 Net balance at end of year 131,702 120,165 Plus: reinsurance recoverable 37,282 39,513 Balance at end of year $ 168,984 $ 159,678
Specialty Health Segment Member | Health Insurance Product Line
Schedule of Liability for Unpaid Claims and Claims Adjustment Expense	Specialty Health Segment Health Insurance Claims Six Months Ended June 30, 2019 2018 Balance at beginning of year $ 26,068 $ 32,904 Less: reinsurance recoverable 851 762 Net balance at beginning of year 25,217 32,142 Amount incurred, related to: Current year 25,855 26,747 Prior years (1,622) (7,174) Total incurred 24,233 19,573 Amount paid, related to: Current year 7,838 7,336 Prior years 13,157 16,662 Total paid 20,995 23,998 Net balance at end of year 28,455 27,717 Plus: reinsurance recoverable 445 683 Balance at end of year $ 28,900 $ 28,400

Stockholders' Equity Note Dis_2

Stockholders' Equity Note Disclosure [Text Block]: Schedule of Accumulated Other Comprehensive Income (Loss) (Tables)	6 Months Ended
	Jun. 30, 2019
Tables/Schedules
Schedule of Accumulated Other Comprehensive Income (Loss)	Three Months Ended Six Months Ended June 30, June 30, 2019 2018 2019 2018 Beginning balance $ (2,641) $ (8,985) $ (8,310) $ (4,598) Cumulative-effect of new accounting principles - - - (350) Other comprehensive income (loss): Other comprehensive income (loss) before reclassifications 5,935 (2,541) 11,077 (6,442) Amounts reclassified from accumulated OCI (996) 289 (469) 153 Net other comprehensive income 4,939 (2,252) 10,608 (6,289) Ending balance $ 2,298 $ (11,237) $ 2,298 $ (11,237)

Stockholders' Equity Note Dis_3

Stockholders' Equity Note Disclosure [Text Block]: Reclassification out of Accumulated Other Comprehensive Income (Tables)	6 Months Ended
	Jun. 30, 2019
Tables/Schedules
Reclassification out of Accumulated Other Comprehensive Income	Three Months Ended Six Months Ended June 30, June 30, 2019 2018 2019 2018 Unrealized gains (losses) on available-for-sale securities reclassified during the period to the following income statement line items: Net investment gains (losses) $ 1,271 $ (366) $ 1,249 $ (195) Net impairment losses recognized in earnings - - (646) - Income (loss) before income tax 1,271 (366) 603 (195) Tax effect 275 (77) 134 (42) Net income (loss) $ 996 $ (289) $ 469 $ (153)

Compensation and Employee Ben_2

Compensation and Employee Benefit Plans [Text Block]: Schedule of Share-based Compensation, Stock Options, Activity (Tables)	6 Months Ended
	Jun. 30, 2019
Tables/Schedules
Schedule of Share-based Compensation, Stock Options, Activity	Shares Weighted- Average Under Option Exercise Price December 31, 2018 567,384 $ 19.40 Granted 424,380 37.38 Exercised (192,050) 9.34 Forfeited (4,000) 22.20 June 30, 2019 795,714 $ 31.40

Segment Reporting Disclosure _2

Segment Reporting Disclosure [Text Block]: Schedule of Segment Reporting Information, by Segment (Tables)	6 Months Ended
	Jun. 30, 2019
Tables/Schedules
Schedule of Segment Reporting Information, by Segment	Three Months Ended Six Months Ended June 30, June 30, 2019 2018 2019 2018 Revenues: Specialty Health $ 47,743 $ 49,087 $ 101,182 $ 99,851 Group disability, life, DBL and PFL 42,914 35,222 83,043 71,681 Individual life, annuities and other (A) 404 445 822 912 Medical Stop-Loss (A) 2 11 4 23 Corporate 2,604 546 3,273 1,077 93,667 85,311 188,324 173,544 Net investment gains (losses) 1,455 (423) 1,626 (352) Net impairment losses recognized in earnings - - (646) - Total revenues $ 95,122 $ 84,888 $ 189,304 $ 173,192 Income before income taxes Specialty Health (B) $ 2,823 $ 7,255 $ 12,481 $ 12,724 Group disability, life, DBL and PFL 5,038 4,699 9,202 10,645 Individual life, annuities and other (A) (C) (314) (126) (767) (294) Medical Stop-Loss (A) 213 70 285 164 Corporate (709) (1,981) (3,141) (4,339) 7,051 9,917 18,060 18,900 Net investment gains (losses) 1,455 (423) 1,626 (352) Net impairment losses recognized in earnings - (646) - Income before income taxes $ 8,506 $ 9,494 $ 19,040 $ 18,548 (A) (B) (C)

Organization, Consolidation, _6

Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] (Details) - USD ($) $ in Thousands	1 Months Ended
	May 31, 2019	Jun. 30, 2019	Dec. 31, 2018
Stockholders' Equity Attributable to Noncontrolling Interest		$ 43	$ 2,682
GeneveAffiliatedEntityMember
EntityCommonStockOutstandingOwnershipPercent		61.00%
HealthInsurance.orgSubsidairyMember
Business Combination, Consideration Transferred	$ 4,700
Stockholders' Equity Attributable to Noncontrolling Interest	2,380
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase of Interest by Parent	$ 1,012

Organization, Consolidation, _7

Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]: New Accounting Pronouncements, Policy [Policy Text Block] (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Operating Lease, Right-of-Use Asset	$ 6,791
Other Liabilities	54,420	$ 53,133
Operating Lease, Liability	$ 7,417
Adjustments for New Accounting Pronouncement
Operating Lease, Right-of-Use Asset		7,010
Other Liabilities		(687)
Operating Lease, Liability		$ 7,697

Earnings Per Share _Text Bloc_2

Earnings Per Share [Text Block] (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Details
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements	19	329	68	286

Cash and Cash Equivalents Dis_3

Cash and Cash Equivalents Disclosure: Schedule of Cash and Cash Equivalents (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018	Jun. 30, 2018	Dec. 31, 2017
Cash and Cash Equivalents, at Carrying Value	$ 14,982	$ 26,173	$ 21,252
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	18,276	$ 30,807	26,493	$ 32,197
Other Assets
Restricted Cash	$ 3,294		$ 5,241

Investments in Debt and Marke_6

Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Debt Securities, Available-for-sale [Table Text Block] (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Debt Securities, Available-for-sale, Amortized Cost	$ 458,503	$ 463,985
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	5,590	1,055
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	2,667	11,576
Debt Securities, Available-for-sale	461,426	453,464
Corporate Debt Securities
Debt Securities, Available-for-sale, Amortized Cost	234,938	202,194
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	3,223	701
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	1,361	5,406
Debt Securities, Available-for-sale	236,800	197,489
Collateralized Mortgage Backed Securities
Debt Securities, Available-for-sale, Amortized Cost	5,745	6,092
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	10	0
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	3	252
Debt Securities, Available-for-sale	5,752	5,840
US Treasury Securities
Debt Securities, Available-for-sale, Amortized Cost	31,829	63,231
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	253	1
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	103	423
Debt Securities, Available-for-sale	31,979	62,809
US Government-sponsored Enterprises Debt Securities
Debt Securities, Available-for-sale, Amortized Cost	6,414	6,596
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	0	0
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	111	110
Debt Securities, Available-for-sale	6,303	6,486
US States and Political Subdivisions Debt Securities
Debt Securities, Available-for-sale, Amortized Cost	166,727	172,860
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	1,785	302
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	1,083	5,228
Debt Securities, Available-for-sale	167,429	167,934
Debt Security, Government, Non-US
Debt Securities, Available-for-sale, Amortized Cost	6,880	7,039
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	153	51
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	6	46
Debt Securities, Available-for-sale	7,027	7,044
Redeemable Preferred Stock
Debt Securities, Available-for-sale, Amortized Cost	5,970	5,970
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	166	0
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	0	111
Debt Securities, Available-for-sale	$ 6,136	5,859
US Government Agencies Debt Securities
Debt Securities, Available-for-sale, Amortized Cost		3
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax		0
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax		0
Debt Securities, Available-for-sale		$ 3

Investments in Debt and Marke_7

Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Investments Classified by Contractual Maturity Date (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Details
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost	$ 39,315
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value	39,331
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost	168,512
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value	170,281
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Through Ten Years, Amortized Cost	162,244
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Through Ten Years, Fair Value	164,144
Debt Securities, Available-for-sale, Allocated and Single Maturity Date, Maturity, after 10 Years, Amortized Cost	76,273
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after 10 Years, Fair Value	75,615
Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost	12,159
Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value	12,055
Debt Securities, Available-for-sale, Amortized Cost	458,503	$ 463,985
Debt Securities, Available-for-sale	$ 461,426	$ 453,464

Investments in Debt and Marke_8

Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value (Details) $ in Thousands	Jun. 30, 2019USD ($)	Dec. 31, 2018USD ($)
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months	$ 23,509	$ 92,853
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	119	1,730
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	138,602	268,034
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	2,548	9,846
Debt Securities, Available-for-sale, Unrealized Loss Position	162,111	360,887
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	$ 2,667	$ 11,576
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions	6	47
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions	81	115
Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions	87	162
Corporate Debt Securities
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months	$ 7,307	$ 46,988
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	20	1,045
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	57,300	108,738
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	1,341	4,361
Debt Securities, Available-for-sale, Unrealized Loss Position	64,607	155,726
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	1,361	5,406
Collateralized Mortgage Backed Securities
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months	0	847
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	0	37
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	4,095	4,993
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	3	215
Debt Securities, Available-for-sale, Unrealized Loss Position	4,095	5,840
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	3	252
US Treasury Securities
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months	5,433	6,138
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	69	15
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	18,135	31,693
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	34	408
Debt Securities, Available-for-sale, Unrealized Loss Position	23,568	37,831
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	103	423
US Government-sponsored Enterprises Debt Securities
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months	0	0
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	0	0
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	6,297	6,478
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	111	110
Debt Securities, Available-for-sale, Unrealized Loss Position	6,297	6,478
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	111	110
US States and Political Subdivisions Debt Securities
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months	10,769	33,021
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	30	522
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	51,116	113,297
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	1,053	4,706
Debt Securities, Available-for-sale, Unrealized Loss Position	61,885	146,318
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	1,083	5,228
Debt Security, Government, Non-US
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months	0	0
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	0	0
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	1,659	2,835
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	6	46
Debt Securities, Available-for-sale, Unrealized Loss Position	1,659	2,835
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	$ 6	46
Redeemable Preferred Stock
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months		5,859
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss		111
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer		0
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss		0
Debt Securities, Available-for-sale, Unrealized Loss Position		5,859
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss		$ 111

Investments in Debt and Marke_9

Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Realized Gain (Loss) on Investments (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Details
Debt Securities, Available-for-sale, Realized Gain (Loss), Excluding Other-than-temporary Impairment	$ 1,271	$ (366)	$ 1,249	$ (195)
Equity Securities, FV-NI, Realized Gain (Loss)	0	(5)	0	(5)
Debt and Equity Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment	1,271	(371)	1,249	(200)
Equity Securities, FV-NI, Unrealized Gain (Loss)	184	(52)	377	(152)
Debt and Equity Securities, Gain (Loss)	1,455	(423)	1,626	(352)
Gain (Loss) on Sale of Other Investments	0	0	0	0
Gain (Loss) on Investments	$ 1,455	$ (423)	$ 1,626	$ (352)

Investments in Debt and Mark_10

Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Details
Available-for-sale Securities, Gross Realized Gains	$ 1,855	$ 73	$ 1,892	$ 319
Available-for-sale Securities, Gross Realized Losses	584	439	643	514
Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net, Available-for-sale Securities	$ 0	$ 0	$ 646	$ 0

Fair Value Disclosures _Text _6

Fair Value Disclosures [Text Block]: Fair Value, Assets Measured on Recurring Basis (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Debt Securities, Available-for-sale	$ 461,426	$ 453,464
Equity Securities, FV-NI	5,543	5,166
Corporate Debt Securities
Debt Securities, Available-for-sale	236,800	197,489
Collateralized Mortgage Backed Securities
Debt Securities, Available-for-sale	5,752	5,840
US Treasury Securities
Debt Securities, Available-for-sale	31,979	62,809
US Government-sponsored Enterprises Debt Securities
Debt Securities, Available-for-sale	6,303	6,486
US States and Political Subdivisions Debt Securities
Debt Securities, Available-for-sale	167,429	167,934
Debt Security, Government, Non-US
Debt Securities, Available-for-sale	7,027	7,044
Redeemable Preferred Stock
Debt Securities, Available-for-sale	6,136	5,859
US Government Agencies Debt Securities
Debt Securities, Available-for-sale		3
Fair Value, Recurring
Debt Securities, Available-for-sale	461,426	453,464
Equity Securities, FV-NI	5,543	5,166
Assets, Fair Value Disclosure	466,969	458,630
Fair Value, Recurring | Corporate Debt Securities
Debt Securities, Available-for-sale	236,800	197,489
Fair Value, Recurring | Collateralized Mortgage Backed Securities
Debt Securities, Available-for-sale	5,752	5,840
Fair Value, Recurring | US Treasury Securities
Debt Securities, Available-for-sale	31,979	62,809
Fair Value, Recurring | US Government-sponsored Enterprises Debt Securities
Debt Securities, Available-for-sale	6,303	6,486
Fair Value, Recurring | US States and Political Subdivisions Debt Securities
Debt Securities, Available-for-sale	167,429	167,934
Fair Value, Recurring | Debt Security, Government, Non-US
Debt Securities, Available-for-sale	7,027	7,044
Fair Value, Recurring | Redeemable Preferred Stock
Debt Securities, Available-for-sale	6,136	5,859
Fair Value, Recurring | Common Stock
Equity Securities, FV-NI	2,649	2,366
Fair Value, Recurring | Nonredeemable Preferred Stock
Equity Securities, FV-NI	2,894	2,800
Fair Value, Recurring | US Government Agencies Debt Securities
Debt Securities, Available-for-sale		3
Fair Value, Inputs, Level 1 | Fair Value, Recurring
Debt Securities, Available-for-sale	6,136	5,859
Equity Securities, FV-NI	5,543	5,166
Assets, Fair Value Disclosure	11,679	11,025
Fair Value, Inputs, Level 1 | Fair Value, Recurring | Corporate Debt Securities
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 1 | Fair Value, Recurring | Collateralized Mortgage Backed Securities
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 1 | Fair Value, Recurring | US Treasury Securities
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 1 | Fair Value, Recurring | US Government-sponsored Enterprises Debt Securities
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 1 | Fair Value, Recurring | US States and Political Subdivisions Debt Securities
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 1 | Fair Value, Recurring | Debt Security, Government, Non-US
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 1 | Fair Value, Recurring | Redeemable Preferred Stock
Debt Securities, Available-for-sale	6,136	5,859
Fair Value, Inputs, Level 1 | Fair Value, Recurring | Common Stock
Equity Securities, FV-NI	2,649	2,366
Fair Value, Inputs, Level 1 | Fair Value, Recurring | Nonredeemable Preferred Stock
Equity Securities, FV-NI	2,894	2,800
Fair Value, Inputs, Level 1 | Fair Value, Recurring | US Government Agencies Debt Securities
Debt Securities, Available-for-sale		0
Fair Value, Inputs, Level 2 | Fair Value, Recurring
Debt Securities, Available-for-sale	453,670	445,896
Equity Securities, FV-NI	0	0
Assets, Fair Value Disclosure	453,670	445,896
Fair Value, Inputs, Level 2 | Fair Value, Recurring | Corporate Debt Securities
Debt Securities, Available-for-sale	236,800	197,489
Fair Value, Inputs, Level 2 | Fair Value, Recurring | Collateralized Mortgage Backed Securities
Debt Securities, Available-for-sale	5,752	5,840
Fair Value, Inputs, Level 2 | Fair Value, Recurring | US Treasury Securities
Debt Securities, Available-for-sale	31,979	62,809
Fair Value, Inputs, Level 2 | Fair Value, Recurring | US Government-sponsored Enterprises Debt Securities
Debt Securities, Available-for-sale	6,303	6,486
Fair Value, Inputs, Level 2 | Fair Value, Recurring | US States and Political Subdivisions Debt Securities
Debt Securities, Available-for-sale	165,809	166,225
Fair Value, Inputs, Level 2 | Fair Value, Recurring | Debt Security, Government, Non-US
Debt Securities, Available-for-sale	7,027	7,044
Fair Value, Inputs, Level 2 | Fair Value, Recurring | Redeemable Preferred Stock
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 2 | Fair Value, Recurring | Common Stock
Equity Securities, FV-NI	0	0
Fair Value, Inputs, Level 2 | Fair Value, Recurring | Nonredeemable Preferred Stock
Equity Securities, FV-NI	0	0
Fair Value, Inputs, Level 2 | Fair Value, Recurring | US Government Agencies Debt Securities
Debt Securities, Available-for-sale		3
Fair Value, Inputs, Level 3 | Fair Value, Recurring
Debt Securities, Available-for-sale	1,620	1,709
Equity Securities, FV-NI	0	0
Assets, Fair Value Disclosure	1,620	1,709
Fair Value, Inputs, Level 3 | Fair Value, Recurring | Corporate Debt Securities
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 3 | Fair Value, Recurring | Collateralized Mortgage Backed Securities
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 3 | Fair Value, Recurring | US Treasury Securities
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 3 | Fair Value, Recurring | US Government-sponsored Enterprises Debt Securities
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 3 | Fair Value, Recurring | US States and Political Subdivisions Debt Securities
Debt Securities, Available-for-sale	1,620	1,709
Fair Value, Inputs, Level 3 | Fair Value, Recurring | Debt Security, Government, Non-US
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 3 | Fair Value, Recurring | Redeemable Preferred Stock
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 3 | Fair Value, Recurring | Common Stock
Equity Securities, FV-NI	0	0
Fair Value, Inputs, Level 3 | Fair Value, Recurring | Nonredeemable Preferred Stock
Equity Securities, FV-NI	$ 0	0
Fair Value, Inputs, Level 3 | Fair Value, Recurring | US Government Agencies Debt Securities
Debt Securities, Available-for-sale		$ 0

Fair Value Disclosures _Text _7

Fair Value Disclosures [Text Block]: Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value, Beginning Balance	$ 1,664	$ 1,836	$ 1,709	$ 1,876
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)	(6)	(8)	(14)	(15)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	(38)	(34)	(75)	(67)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value, Ending Balance	1,620	1,794	1,620	1,794
Gain (Loss) on Investments
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings	0	0	0	0
US States and Political Subdivisions Debt Securities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value, Beginning Balance	1,664	1,836	1,709	1,876
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)	(6)	(8)	(14)	(15)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	(38)	(34)	(75)	(67)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value, Ending Balance	1,620	1,794	1,620	1,794
US States and Political Subdivisions Debt Securities | Gain (Loss) on Investments
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings	$ 0	$ 0	$ 0	$ 0

Fair Value Disclosures _Text _8

Fair Value Disclosures [Text Block]: Fair Value, by Balance Sheet Grouping (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Short-term Investments	$ 50	$ 1,050
Deposit Contracts, Liabilities	141,523	141,635
Policyholder Account Balance	11,757	10,939
Estimate of Fair Value Measurement | Fair Value, Inputs, Level 1
Short-term Investments	50	1,050
Deposit Contracts, Liabilities	0	0
Policyholder Account Balance	0	0
Estimate of Fair Value Measurement | Fair Value, Inputs, Level 2
Short-term Investments	0	0
Deposit Contracts, Liabilities	141,539	141,662
Policyholder Account Balance	11,757	10,939
Reported Value Measurement
Short-term Investments	50	1,050
Deposit Contracts, Liabilities	141,523	141,635
Policyholder Account Balance	$ 11,757	$ 10,939

Variable Interest Entity Disc_2

Variable Interest Entity Disclosure [Text Block] (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018
Income (Loss) from Equity Method Investments			$ 515	$ (765)
Payments to Acquire Other Investments			3,000	0
Gain (Loss) on Disposition of Other Assets			3,589	0
PetsBest Member
Equity Securities without Readily Determinable Fair Value, Amount					$ 500
Gain (Loss) on Disposition of Other Assets			3,589
Other Investments | Variable Interest Entity, Not Primary Beneficiary, Aggregated Disclosure
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	$ 6,524		6,524
Ebix Health Exchange Member | Selling, General and Administrative Expenses
Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party	525	$ 1,926	987	4,473
Ebix Health Exchange Member | Other Assets
Due from Related Parties	1,817		1,817		1,842
Ebix Health Exchange Member | Accounts Payable and Accrued Liabilities
Due to Related Parties	253		253		910
Ebix Health Exchange Holdings Member
Equity Method Investments	4,762		4,762		$ 6,425
Income (Loss) from Equity Method Investments	$ (1,121)	$ (255)	$ (1,663)	$ (771)

BusinessCombinationAndDeconso_3

BusinessCombinationAndDeconsolidationDisclosure (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	$ 1,500		$ 1,500
Revenues	95,122	$ 84,888	189,304	$ 173,192
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	6,916	$ 6,842	15,806	$ 13,890
Series of Individually Immaterial Business Acquisitions
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value			720
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Loss			237
Business Combination, Consideration Transferred			8,534
Goodwill, Acquired During Period			9,508
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	1,500		1,500
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net	(254)		(254)
Revenues	916		1,424
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ (406)		$ (383)

BusinessCombinationAndDeconso_4

BusinessCombinationAndDeconsolidationDisclosure: Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details) $ in Thousands	Jun. 30, 2019USD ($)
Series of Individually Immaterial Business Acquisitions
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents	$ 582
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	1,500
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other	1,301
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets	3,383
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other	3,637
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities	3,637
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net	(254)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	$ 1,500

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets Disclosure [Text Block] (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018
Goodwill	$ 60,205		$ 60,205		$ 50,697
Intangible Assets, Net (Excluding Goodwill)	13,995		13,995		$ 13,163
Amortization of Intangible Assets	309	$ 382	668	$ 743
Series of Individually Immaterial Business Acquisitions
Goodwill, Acquired During Period			$ 9,508
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life			17 years
Specialty Health Segment Member
Goodwill, Acquired During Period			$ 9,508
Finite-lived Intangible Assets Acquired			1,500
Amortization of Intangible Assets	$ 309	$ 382	$ 668	$ 743

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets Disclosure [Text Block]: Schedule of Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Finite-Lived Intangible Assets, Gross	$ 20,533	$ 19,033
Finite-Lived Intangible Assets, Accumulated Amortization	14,515	13,847
Customer Relationships
Finite-Lived Intangible Assets, Gross	18,753	17,253
Finite-Lived Intangible Assets, Accumulated Amortization	13,971	13,419
Internet Domain Names
Finite-Lived Intangible Assets, Gross	1,000	1,000
Finite-Lived Intangible Assets, Accumulated Amortization	275	225
Computer Software, Intangible Asset
Finite-Lived Intangible Assets, Gross	780	780
Finite-Lived Intangible Assets, Accumulated Amortization	$ 269	$ 203

Goodwill and Intangible Asset_6

Goodwill and Intangible Assets Disclosure [Text Block]: Schedule of Indefinite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Indefinite-lived Intangible Assets (Excluding Goodwill)	$ 7,977	$ 7,977
Licensing Agreements
Indefinite-lived Intangible Assets (Excluding Goodwill)	$ 7,977	$ 7,977

Income Tax Disclosure _Text B_2

Income Tax Disclosure [Text Block] (Details)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Details
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%
Effective Income Tax Rate Reconciliation, Newly Enacted Federal Statutory Income Tax Rate, Fiscal Year Blended Rate, Percent		28.00%

Lessee, Operating Leases (Detai

Lessee, Operating Leases (Details) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2019USD ($)	Jun. 30, 2019USD ($)
Operating Lease, Right-of-Use Asset	$ 6,791	$ 6,791
Operating Lease, Liability	$ 7,417	$ 7,417
Operating Lease, Weighted Average Discount Rate, Percent	6.78%	6.78%
Lessee, Operating Lease, Renewal Term	5 years	5 years
Operating Lease, Weighted Average Remaining Lease Term	5 years	5 years
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$ 583	$ 639
Series of Individually Immaterial Business Acquisitions
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability		$ 435
Minimum
Lessee, Operating Lease, Term of Contract	1 year	1 year
Maximum
Lessee, Operating Lease, Term of Contract	8 years	8 years

Lessee, Operating Leases_ Lea_2

Lessee, Operating Leases: Lease, Cost (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2019
Details
Operating Lease, Cost	$ 575	$ 1,111
Short-term Lease, Cost	50	74
Variable Lease, Cost	132	206
Lease, Cost	757	1,391
Operating Lease, Payments	568	1,173
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$ 583	$ 639

Lessee, Operating Leases_ Les_2

Lessee, Operating Leases: Lessee, Operating Lease, Liability, Maturity (Details) $ in Thousands	Jun. 30, 2019USD ($)
Details
Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months	$ 2,339
Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two	1,845
Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three	1,608
Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four	1,113
Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five	486
Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five	1,321
Lessee, Operating Lease, Liability, Payments, Due	8,712
Lessee, Operating Lease, Liability, Undiscounted Excess Amount	(1,295)
Operating Lease, Liability	$ 7,417

Liability for Future Policy B_3

Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]: Schedule of Liability for Unpaid Claims and Claims Adjustment Expense (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Liability for Claims and Claims Adjustment Expense, Beginning Balance	$ 160,115	$ 168,683
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Beginning Balance	38,122	42,136
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Beginning Balance	121,993	126,547
Current Year Claims and Claims Adjustment Expense	96,736	84,871
Prior Year Claims and Claims Adjustment Expense	(8,141)	(13,189)
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims	88,595	71,682
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year	41,644	35,956
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years	37,242	42,108
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid	78,886	78,064
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Ending Balance	131,702	120,165
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Ending Balance	37,282	39,513
Liability for Claims and Claims Adjustment Expense, Ending Balance	168,984	159,678
Specialty Health Segment Member
Prior Year Claims and Claims Adjustment Expense	(3,158)	(8,398)
Specialty Health Segment Member | Health Insurance Product Line
Liability for Claims and Claims Adjustment Expense, Beginning Balance	26,068	32,904
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Beginning Balance	851	762
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Beginning Balance	25,217	32,142
Current Year Claims and Claims Adjustment Expense	25,855	26,747
Prior Year Claims and Claims Adjustment Expense	(1,622)	(7,174)
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims	24,233	19,573
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year	7,838	7,336
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years	13,157	16,662
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid	20,995	23,998
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Ending Balance	28,455	27,717
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Ending Balance	445	683
Liability for Claims and Claims Adjustment Expense, Ending Balance	$ 28,900	$ 28,400

Liability for Future Policy B_4

Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block] (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Prior Year Claims and Claims Adjustment Expense	$ (8,141)	$ (13,189)
Specialty Health Segment Member
Prior Year Claims and Claims Adjustment Expense	(3,158)	(8,398)
Specialty Health Segment Member | Health Insurance Product Line
Prior Year Claims and Claims Adjustment Expense	(1,622)	(7,174)
Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net	28,455
Group Disability, Life, DBL And PFL Segment Member
Prior Year Claims and Claims Adjustment Expense	(4,230)	(3,345)
Individual life annuities and other Segment Member
Prior Year Claims and Claims Adjustment Expense	(594)	(998)
Medical Stop-Loss Segment Member
Prior Year Claims and Claims Adjustment Expense	$ (159)	$ (448)

Stockholders' Equity Note Dis_4

Stockholders' Equity Note Disclosure [Text Block]: Schedule of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Accumulated other comprehensive income (loss)			$ (8,310)
Other Comprehensive Income (Loss), Net of Tax	$ 4,939	$ (2,252)	10,608	$ (6,289)
Accumulated other comprehensive income (loss)	2,298		2,298
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent
Accumulated other comprehensive income (loss)	(2,641)	(8,985)	(8,310)	(4,598)
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	5,935	(2,541)	11,077	(6,442)
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	996	(289)	469	(153)
Other Comprehensive Income (Loss), Net of Tax	4,939	(2,252)	10,608	(6,289)
Accumulated other comprehensive income (loss)	2,298	(11,237)	2,298	(11,237)
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent | Accounting Standards Update 2016-01
Cumulative Effect of New Accounting Principle in Period of Adoption	$ 0	$ 0	$ 0	$ (350)

Stockholders' Equity Note Dis_5

Stockholders' Equity Note Disclosure [Text Block]: Reclassification out of Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Gain (Loss) on Investments	$ 1,455	$ (423)	$ 1,626	$ (352)
Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net, Available-for-sale Securities	0	0	646	0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	8,506	9,494	19,040	18,548
Income Tax Expense (Benefit)	1,590	2,652	3,234	4,658
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	6,916	6,842	15,806	13,890
Reclassification out of Accumulated Other Comprehensive Income | AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent
Gain (Loss) on Investments	1,271	(366)	1,249	(195)
Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net, Available-for-sale Securities	0	0	646	0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	1,271	(366)	603	(195)
Income Tax Expense (Benefit)	275	(77)	134	(42)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 996	$ (289)	$ 469	$ (153)

Compensation and Employee Ben_3

Compensation and Employee Benefit Plans [Text Block]: Schedule of Share-based Compensation, Stock Options, Activity (Details) - Share-based Payment Arrangement, Option	6 Months Ended
	Jun. 30, 2019$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Beginning Balance | shares	567,384
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Beginning Balance | $ / shares	$ 19.40
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares	424,380
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares	$ 37.38
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares	192,050
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | $ / shares	$ 9.34
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares	4,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | $ / shares	$ 22.20
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance | shares	795,714
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Ending Balance | $ / shares	$ 31.40

Compensation and Employee Ben_4

Compensation and Employee Benefit Plans [Text Block] (Details) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Proceeds from Stock Options Exercised	$ 44	$ 134
Payment, Tax Withholding, Share-based Payment Arrangement	$ 2,397	$ 0
Share-based Payment Arrangement, Option
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 8.31
Proceeds from Stock Options Exercised	$ 44
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value	5,002
Share-based Payment Arrangement, Exercise of Option, Tax Benefit	737
Payment, Tax Withholding, Share-based Payment Arrangement	$ 2,397

Cash Flow, Supplemental Discl_2

Cash Flow, Supplemental Disclosures [Text Block] (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Details
Income Taxes Paid (Refunds), Net	$ 388	$ 1,104

Commitments and Contingencies_2

Commitments and Contingencies Disclosure [Text Block] (Details) - Pending Litigation $ in Thousands	1 Months Ended
	May 31, 2017USD ($)
Loss Contingency, Nature, Injunctive Relief and Damages Member
Loss Contingency, Damages Sought, Value	$ 50,000
Loss Contingency, Nature, Amounts Allegedly Owed To Plaintiff Member
Loss Contingency, Damages Sought, Value	$ 3,082

Segment Reporting Disclosure _3

Segment Reporting Disclosure [Text Block]: Schedule of Segment Reporting Information, by Segment (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Revenues	$ 95,122	$ 84,888	$ 189,304	$ 173,192
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	8,506	9,494	19,040	18,548
Amortization of Intangible Assets	309	382	668	743
Operating Segments
Revenues	93,667	85,311	188,324	173,544
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	7,051	9,917	18,060	18,900
Segment Reconciling Items | Gain (Loss) on Investments
Revenues	1,455	(423)	1,626	(352)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	1,455	(423)	1,626	(352)
Segment Reconciling Items | Net Impairment Losses Recognized In Earnings
Revenues	0	0	(646)	0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	0	0	(646)	0
Specialty Health Segment Member
Revenues	47,743	49,087	101,182	99,851
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	2,823	7,255	12,481	12,724
Amortization of Intangible Assets	309	382	668	743
Group Disability, Life, DBL And PFL Segment Member
Revenues	42,914	35,222	83,043	71,681
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	5,038	4,699	9,202	10,645
Individual life annuities and other Segment Member
Revenues	404	445	822	912
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	(314)	(126)	(767)	(294)
Amortization of Other Deferred Charges	197	219	402	456
Medical Stop-Loss Segment Member
Revenues	2	11	4	23
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	213	70	285	164
Corporate Segment
Revenues	2,604	546	3,273	1,077
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$ (709)	$ (1,981)	$ (3,141)	$ (4,339)